{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T22:28:21Z","timestamp":1700432901049},"reference-count":7,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2016,3,14]],"date-time":"2016-03-14T00:00:00Z","timestamp":1457913600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1111\/ejh.12639","type":"journal-article","created":{"date-parts":[[2015,7,24]],"date-time":"2015-07-24T14:57:28Z","timestamp":1437749848000},"page":"329-330","source":"Crossref","is-referenced-by-count":2,"title":["<i><scp>BCR<\/scp>\u2010<scp>ABL<\/scp>1<\/i> b3a2 and b2a2 transcripts in chronic myeloid leukemia: does it matter?"],"prefix":"10.1111","volume":"96","author":[{"given":"Marc","family":"De Braekeleer","sequence":"first","affiliation":[{"name":"Laboratoire d'Histologie, Embryologie et Cytog\u00e9n\u00e9tique Facult\u00e9 de M\u00e9decine et des Sciences de la Sant\u00e9 Universit\u00e9 de Brest Brest France"},{"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM), U1078 Brest France"},{"name":"Service de Cytog\u00e9n\u00e9tique et Biologie de la Reproduction H\u00f4pital Morvan, CHRU Brest Brest France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,3,14]]},"reference":[{"key":"e_1_2_2_2_1","article-title":"Gender and BCR\u2010ABL transcript type are correlated with molecular response to imatinib treatment in patients with chronic myeloid leukemia","author":"Lin HX","year":"2015","journal-title":"Eur J Haematol"},{"key":"e_1_2_2_3_1","doi-asserted-by":"publisher","DOI":"10.4081\/hr.2011.e3"},{"key":"e_1_2_2_4_1","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1182\/blood.V110.11.1939.1939","article-title":"Better Molecular Response to Imatinib for Patients (pts) with Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) Carrying the b3a2 Transcript Compared to b2a2","volume":"110","author":"Vega\u2010Ruiz A","year":"2007","journal-title":"Blood"},{"key":"e_1_2_2_5_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2009.009134"},{"key":"e_1_2_2_6_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2013.096537"},{"key":"e_1_2_2_7_1","doi-asserted-by":"publisher","DOI":"10.6026\/97320630010108"},{"key":"e_1_2_2_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.210"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fejh.12639","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ejh.12639","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T23:46:35Z","timestamp":1696290395000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ejh.12639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,14]]},"references-count":7,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["10.1111\/ejh.12639"],"URL":"https:\/\/doi.org\/10.1111\/ejh.12639","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,14]]}}}